Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia
Clinical trial NCT05728944 · COMPLETED
Trial details
- NCT number
- NCT05728944
- Sponsor
- LENZ Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-06
- Primary completion
- 2023-12-14
- Enrollment
- 229
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.